Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI

Figure 5

Comparison of long-term risk of primary ischemic endpoint between DAPT interruption ≤12 months and DAPT maintenance > 12 months according to subgroups. The cumulative incidence and hazard ratio with 95% confidence interval of primary efficacy endpoint are presented between DAPT > 12 months and DAPT ≤ 12 months according to the components of the ESC stent-driven high ischemic risk definition (a) and number of ESC stent-driven high ischemic risk criteria fulfilled (b). CAD = coronary artery disease; HIR = high ischemic risk; and other abbreviations are as in Figure 1.

(a)

(b)